39 results about "Cerebrosclerosis" patented technology

The invention provides a drug, namely ginkgo biloba general vein medicine for treating a cardiovascular disease. The drug is prepared from the following components in parts by weight of 300-400 parts of ginkgo leaf, 30-80 parts of pseudo-ginseng, 300-400 parts of root of red-rooted salvia, 100-200 parts of ligusticum wallichii, and 100-200 parts of astragalus mongholicus. The drug has the effects of invigorating bolt elimination, regulating qi to alleviate pain, expanding coronary or cerebral arteries, restricting platelet aggregation, reducing blood fat and blood viscosity, and the like. The drug is used for treating coronary heart disease, stenocardia, myocardial infarction, cerebral arteriosclerosis, hyperlipidemia, apoplexy (apoplexia) and sequelae thereof; and furthermore, the drug also has good analgesic anti-inflammatory effects. The drug has significant curative effects on the cardiovascular disease, thoracic obstruction caused by qi-stagnation and blood stasis, namely coronary heart disease angina, giddiness namely cerebral arteriosclerosis and the like, is rapid to recover after being taken, low in recurrence rate, high in security, free of side effect, simple and convenient to prepare, and the like.

The present invention relates to Chinese medicine for treating high viscosity blood syndrome and its preparation process. High viscosity blood syndrome and thrombosis will result in many kinds of cardiac and cerebral vascular diseases. The Chinese medicine has astragalus root and Chuanxiong rhizome with functions of benefiting vital energy and promoting blood circulation as main component, earthworm and rhubarb with functions of dispersing blood stasis and dredging meridian as adjuvant component, and desert cistanche, sealwort, red sage and curcuma root as assistant component. The Chinese medicine has obvious curative effect on coronary heart disease, angina pectoris, hypertension, etc. and no toxic side effect.

A mixture for preventing and treating the free radical oxidizing damage of biologic cells, such as presenile dementia, Parkinson's disease, cerebrosclerosis, apoplexy, cardiovascular disease, tumor, etc is prepared from VC, VE and melatonin.

A solid lipid nanoparticle of vinpocetin used for preparing orally taken medicine or injection for treating the circulatory disturbance type cerebrovascular diseases including cerebral infarction, sequelae of encephalorrhagia, cerebral arteriosclerosis, etc, improving cerebral function and delaying cerebral senility is prepared from xinpocetin, phosphatide, emulsifier and additive.

The compound panoxatriol saponin with physiological activity contains panoxatriol saponin, gingko extractive, theanine and supplementary material is prepared into various preparations. The compound panoxatriol saponin can treat cerebral atherosclerosis, senile dementia, etc. by means of the functions of strengthening the activity of cerebral cell and cerebral nerve cell, improving brain's oxygen and blood supplying state, etc.

An interior-applied Chinese medicine for treating the ascendant hyperactivity of liver yang cerebral arteriosclerosis is prepared from 14 Chinese-medicinal materials including red sage root, wolfberry fruit, fleece flower root, ganoderma, etc.

The invention relates to an oral solid medicine composition for nervous system diseases. The composition is a tablet and comprises an active component, lactose anhydrous, a disintegrating agent and an adhesive. The medicine composition can be used for a cerebrovascular disease, used for improving brain metabolism and mental symptoms, activating respiratory activity of brain mitochondria, improving brain energy metabolism of brain ischemia, increasing a utilization ratio of glucose in a brain, allowing adenosine triphosphate produced in the brain to be increased, preventing brain mitochondrion from generating peroxidized lipin, and inhibiting a membrane obstruction due to lipid peroxidation of a brain mitochondrial membrane, used for brain function injures caused by the chronic cerebrovascular disease, brain trauma and the like, and used for improving mental and behavioral disorders such as a subjective symptom, a language disorder, anxiety, depression, hypomnesia and brain power declining, promoting brain power, activating a brain mitochondrion function, improving the brain energy metabolism and a brain function, improving emotion depression, low consciousness, an affective disorder, a language disorder and the like that are caused by a cerebral infarction sequela, a cerebral hemorrhage sequela and cerebral arteriosclerosis, improving brain metabolism, and protecting cranial neural cells.

A Chinese medicine in the form of tablet for treating cerebral arteriosclerosis is prepared from 9 Chinese-medicinal materials including fleece flower root, astragalus root, red sage root, pueraria root, etc. Its preparing process and quality control method are also disclosed.

An interior-applied Chinese medicine for treating the general cerebral arteriosclerosis is prepared from 11 Chinese-medicinal materials including red sage root, wolfberry fruit, fleece flower root, ganoderma, etc.

The invention discloses a przewalsk sage root blood activating medicine and a preparation method thereof. The medicine comprises auxiliary materials and main materials, wherein the auxiliary materials include glycerol, hydroxypropyl methyl cellulose and titanium white; and the main materials include panax notoginseng saponins and przewalsk sage root in a weight ratio of 25 to 312.5. The medicine is prepared inform of tablets by following steps: extracting of the components, mixing, drying and the like. In the invention, panax notoginseng saponins and the przewalsk sage root are combined and glycerol, hydroxypropyl methyl cellulose and titanium white are added, so the przewalsk sage root blood activating medicine can reinforce and improve coronary microcirculation, expand arteria coronaria, increase blood flow in coronary artery, improve the myocardial ischemia and myocardial contractility, regulate rhythm of the heart, reduce rhythm of the heart and blood pressure. The medicine has an obvious treatment effect on cardiovascular and cerebrovascular diseases caused by qi depression to blood stasis, such as coronary disease and cerebral arteriosclerosis and has powerful effects of activating blood, eliminating stasis, regulating qi and relieving pain.

A Chinese medicine for treating cerebral arteriosclerosis, dizziness, headache, carbiopalmus, etc is prepared from 5 Chinese-medicinal materials including pueraria root, red sage root, fleece flower root, pipe fish, etc.

The invention discloses a new form of a traditional Chinese medicine compound and a preparation method thereof. The new form of traditional Chinese medicine compound is used for activating the circulation of blood, dissolving the blood stasis, promoting the restoration of consciousness, taking away the pain, dilating the blood vessel, increasing the coronary artery blood flow and treating the coronary heart disease and the cerebral arteriosclerosis. The preparation method of the traditional Chinese drop pills comprises the following steps: grinding szechuan lovage rhizome, safflower, alisma orientale, achyranthes, radix curcumae, polygala tenuifolia, rhizoma anemones altaicae, spina date seeds and liquorice powder into medical fine power of 150 mesh for later use; adding water to decoct aalvia miltiorrhiza, red paeony root, prepared radix polygoni multiflori, barbary wolfberry fruit, kudzu-vine root and earthworm for 2 hours with a dynamic counter current extraction method, wherein the water is four times the total amount of the aalvia miltiorrhiza, the red paeony root, the prepared radix polygoni multiflori, the barbary wolfberry fruit, the kudzu-vine root and the earthworm; filtering the decoction; concentrating the filtered decoction into thick paste; adding and evenly stirring the thick paste, the medical fine power and dear heart powder to molten polyethylene glycol 4000, wherein the proportion of the thick paste, the medical fine power and the dear heart powder to the molten polyethylene glycol 4000 is 4:7; uniformly mixing; keeping the temperature of the mixture at 70 DEG C; dripping the mixture into liquid paraffin at constant speed; leaching the prepared traditional Chinese drop pills and wiping out the liquid paraffin. Test proves that the traditional Chinese drop pills are more markedly improved in the curative effect and the bioavailability than the original capsules.

The present invention provides a drug Huoxuewang for treating cadiovascular and orthopaedics diseases. The components of the drug comprise, by mass, 30-80 parts of panax notoginsenosidum, 350-450 parts of radix salviae miltiorrhizae and 200-250 parts of shortscape fleabane herb. According to the present invention, ethanol is added to the radix salviae miltiorrhizae coarse powder and the shortscape fleabane herb coarse powder; a reflux extraction treatment is performed two times; the resulting filter residue is added with water, and is decocted; the resulting extracting solution by the ethanol is mixed with the resulting decoction solution by the water, and the resulting mixture is concentrated into condensed extract; the panax notoginsenosidum fine powder is added to the condensed extract to obtain the traditional Chinese drug composition with effects of blood activating and blood stasis dissipating. The traditional Chinese drug composition of the present invention has effectivenesses of blood activating and blood stasis dissipating, swelling subsiding and pain relieving, blood circulation promoting and collateral activating, and the like, and has effects of good pain relieving and inflammation eliminating, acceleration of healing of fracture and wound tissues. The traditional Chinese drug composition of the present invention provides good therapeutic effects for cadiovascular diseases, pectoral stuffiness pain caused by qi-stagnancy and blood stasis, and vertigo, wherein the pectoral stuffiness pain is angina pectoris of the coronary heart disease, the vertigo is cerebral arteriosclerosis. In addition, the traditional Chinese drug composition of the present invention has significant therapeutic effects of quick recovery, low recurrence rate, high safety, no side effects and the like, and the production of the traditional Chinese drug composition is simple.

The invention provides a medicament for treating cardiovascular and orthopedic diseases. The medicament comprises the following components in parts by mass: 30-80 parts of total saponins of panax notoginseseng, 200-250 parts of radix salviae miltiorrhizae, 200-250 parts of gingko leaf and 150-200 parts of ligusticum wallichii. The medicament is prepared by the following steps of: carrying out reflux extraction on radix salviae miltiorrhizae, gingko leaf and ligusticum wallichii coarse powder twice by using ethanol; decocting the residues with water; mixing the ethanol extract and the water decoction, and concentrating into dense extract; adding fine powder of the total saponins of panax notoginseseng to obtain the traditional Chinese medicinal composition with the effect of activating blood circulation to remove stasis. The traditional Chinese medicinal composition has the effects of activating blood circulation to remove stasis, reducing swelling, relieving pain, promoting qi circulation and activating collaterals, also has excellent functions of easing pain, diminishing inflammation, resisting allergy, reinforcing body immunity, and accelerating healing of bone fracture and wound tissues. The medicament has a good curative effect on cardiovascular diseases, thoracic obstruction of qi in the chest (coronary heart disease and stenocardia) caused by qi stagnation and blood stasis, dizziness (cerebral arteriosclerosis) and stroke caused by blood clots, has remarkable curative effects of quick recovery, low relapse rate, high safety and no side effect, and is convenient to manufacture.

The invention discloses traditional Chinese medicine fumigating and soaking combined liquid medicine for treating hyperlipidemia cerebral arteriosclerosis and belongs to the technical field of traditional Chinese medicine. The combined liquid medicine is prepared by soaking 80-120 g of honeysuckle, 10-40 g of saffron crocus, 170-220 g of hawthorns, 170-220 g of the root of red-rooted salvia, 170-220 g of radix polygoni multiflori, 170-220 g of radix aucklandiae and 15-25 g of borneol by the ratio; the materials of the ratio are soaked in 75% medicinal alcohol of 2000-3000 ml for seven days, and 15-30 ml of azone is added to obtain the traditional Chinese medicine fumigating and soaking combined liquid medicine. The traditional Chinese medicine fumigating and soaking combined liquid medicine obtained finally is used for treating patients with symptoms, and practice has proved that the curative effect is remarkable.

An interior-applied Chinese medicine for treating the action dysfunction cerebral arteriosclerosis is prepared from 15 Chinese-medicinal materials including red sage root, wolfberry fruit, fleece flower root, ganoderma, etc.

The invention discloses a traditional Chinese medicine for treating cerebral arteriosclerosis. The traditional Chinese medicine is characterized by being prepared from the following medicinal materials in parts by weight: 15-20 parts of astragalus root, 10-15 parts of codonopsis pilosula, 4-5 parts of rhizoma cimicifugae, 10-15 parts of kudzuvine root, 8-12 parts of fructus viticis, 7-10 parts of white peony root, 5-8 parts of cortex phellodendri, 15-20 parts of root of red-rooted salvia, 8-12 parts of Szechuan lovage rhizome, 7-10 parts of licorice, 7-10 parts of monkshood, 4-6 parts of hairy holly leaves, 0-10 parts of magnets and 0-8 parts of amur grape stems. A preparation method comprises the steps of weighing the medicinal materials, putting the medicinal materials into a container, adding water of which the quantity is 8 times that of the medicinal materials, decocting for 1.5 hours, and filtering; adding water of which the quantity is 6 times that of filter residues into the filter residues, decocting for 1 hour, and filtering; and mixing the filtrates, concentrating, drying, and filling capsule shells with the dried mixture. Clinical experiments prove that the traditional Chinese medicine achieves a significant effect of treating the cerebral arteriosclerosis by selecting the appropriate medicinal materials and the ratio thereof, is safe and does not have toxic or side effect.

The invention provides a medicament for treating cardiovascular and orthopedic diseases. The medicament comprises the following components in parts by mass: 30-80 parts of total saponins of panax notoginseseng, 200-250 parts of radix salviae miltiorrhizae, 200-250 parts of gingko leaf and 150-200 parts of ligusticum wallichii. The medicament is prepared by the following steps of: carrying out reflux extraction on radix salviae miltiorrhizae, gingko leaf and ligusticum wallichii coarse powder twice by using ethanol; decocting the residues with water; mixing the ethanol extract and the water decoction, and concentrating into dense extract; adding fine powder of the total saponins of panax notoginseseng to obtain the traditional Chinese medicinal composition with the effect of activating blood circulation to remove stasis. The traditional Chinese medicinal composition has the effects of activating blood circulation to remove stasis, reducing swelling, relieving pain, promoting qi circulation and activating collaterals, also has excellent functions of easing pain, diminishing inflammation, resisting allergy, reinforcing body immunity, and accelerating healing of bone fracture and wound tissues. The medicament has a good curative effect on cardiovascular diseases, thoracic obstruction of qi in the chest (coronary heart disease and stenocardia) caused by qi stagnation and blood stasis, dizziness (cerebral arteriosclerosis) and stroke caused by blood clots, has remarkable curative effects of quick recovery, low relapse rate, high safety and no side effect, and is convenient to manufacture.

The invention relates to a vinpocetine freeze-dried preparation for injection and a preparation method thereof. The vinpocetine preparation for injection belongs to a medicine application system and is prepared from, by weight, 1-10 parts of vinpocetine, 5-30 parts of organic solvent, 0.1-20 parts of a surface active agent, 0.1-15 parts of a freezing and drying protecting agent, 0.01-1 part of a pH conditioning agent and the balance water for injection. The vinpocetine freeze-dried preparation can be used for preparing medicine for treating multiple types of insufficient blood supply symptoms and can be further used for treating multiple types of cerebrovascular circulation disorder diseases such as cerebral infarction, cerebral hemorrhage and cerebral arteriosclerosis.

The present invention relates to preparation process and application of medicine for treating cerebral embolism, cerebral angiospasm and other ischemic encephalopathy and cerebral arteriosclerosis. The medicine has the functions of promoting blood circulation to disperse blood clots, relieving spasm and pain, strengthening cerebral and coronary artery. The medicine is prepared with kudzu vine root, ginkgo leaf and borneol, and through washing material, drying, mixing, crushing, ethanol extraction, concentrating extracted liquid, sucking filtering, spray drying, pelletizing and other steps.

The invention discloses a traditional Chinese medicine composition for treating meridian obstruction type cerebral arteriosclerosis. The traditional Chinese medicine composition is characterized by comprising the following medicinal materials in parts by weight: 3-6 parts of Irkutsk Anemone Rhizome, 30-40 parts of Saccharum arundinaceum, 6-10 parts of root of common peony, 1-3 parts of crocus sativus, 6-9 parts of bock greenbrier rhizome, 12-15 parts of broadleaf ainsliaea herb, 3-6 parts of lancifolia hutchina, 12-15 parts of Nepal pennywort herb, 6-9 parts of Ligusticum brachylobum, 10-15 parts of Justicia procumbens, 6-9 parts of Abies chensiensis, 6-9 parts of omoto nipponlily flower and 3-6 parts of cassia twig. The traditional Chinese medicine composition disclosed by the invention is used for treating the meridian obstruction type cerebral arteriosclerosis and is high in effective rate and reliable in curative effect, and the meridian obstruction type cerebral arteriosclerosis does not reoccur after healing.

An interior-applied Chinese medicine for treating the limb numbness type cerebral arteriosclerosis is prepared from 13 Chinese-medicinal materials including red sage root, wolfberry fruit, fleece flower root, ganoderma, etc.

The invention discloses a traditional Chinese medicine composition for treating phlegm stagnation type cerebral arteriosclerosis. The traditional Chinese medicine composition is characterized by being prepared from the following medicinal materials in parts by weight: 3-6 parts of katsumada galangal seed, 5-10 parts of ligusticum wallichii, 20-30 parts of polygonum posumbu, 3-6 parts of exocarpium citri grandis, 9-12 parts of bilobate grewia, 20-30 parts of phaenosperma globosa, 5-10 parts of calamus, 10-15 parts of fourleaf peperomia herb, 6-10 parts of conyza sumatrensis, 9-12 parts of lethariella cladonioides, 20-30 parts of razor clam shell, 10-15 parts of allium caeruleum, 6-10 parts of corylopsis sinensis hemsl., 6-10 parts of rhizoma gastrodiae and 3-6 parts of liquorice. The traditional Chinese medicine composition disclosed by the invention is used for treating phlegm stagnation type cerebral arteriosclerosis, has the advantages of high effective rate and reliable curative effect and avoids relapse after healing.

The invention discloses a new form of a traditional Chinese medicine compound and a preparation method thereof. The new form of traditional Chinese medicine compound is used for activating the circulation of blood, dissolving the blood stasis, promoting the restoration of consciousness, taking away the pain, dilating the blood vessel, increasing the coronary artery blood flow and treating the coronary heart disease and the cerebral arteriosclerosis. The preparation method of the traditional Chinese drop pills comprises the following steps: grinding szechuan lovage rhizome, safflower, alisma orientale, achyranthes, radix curcumae, polygala tenuifolia, rhizoma anemones altaicae, spina date seeds and liquorice powder into medical fine power of 150 mesh for later use; adding water to decoct aalvia miltiorrhiza, red paeony root, prepared radix polygoni multiflori, barbary wolfberry fruit, kudzu-vine root and earthworm for 2 hours with a dynamic counter current extraction method, wherein the water is four times the total amount of the aalvia miltiorrhiza, the red paeony root, the prepared radix polygoni multiflori, the barbary wolfberry fruit, the kudzu-vine root and the earthworm; filtering the decoction; concentrating the filtered decoction into thick paste; adding and evenly stirring the thick paste, the medical fine power and dear heart powder to molten polyethylene glycol 4000,wherein the proportion of the thick paste, the medical fine power and the dear heart powder to the molten polyethylene glycol 4000 is 4:7; uniformly mixing; keeping the temperature of the mixture at 70 DEG C; dripping the mixture into liquid paraffin at constant speed; leaching the prepared traditional Chinese drop pills and wiping out the liquid paraffin. Test proves that the traditional Chinesedrop pills are more markedly improved in the curative effect and the bioavailability than the original capsules.

The invention belongs to the field of traditional Chinese medicine oral thick paste, in particular to an oral thick paste for medically treating cerebral arteriosclerosis and a preparation method thereof. The oral thick paste is prepared from the following raw materials in parts by weight: 100 to 200 parts of brown sugar, 200 to 300 parts of honey, 90 to 110 parts of radix salviae miltiorrhizae, 90 to 110 parts of radix paeoniae rubra, 90 to 110 parts of rhizoma chuanxiong, 90 to 110 parts of radix puerariae, 90 to 110 parts of radix polygoni multiflori, 90 to 110 parts of rhizoma polygonati,90 to 110 parts of flos cartham, 50 to 70 parts of rhizoma gastrodiae, and 20 to 40 parts of ginseng radix et rhizome. The oral thick paste has the advantages that the compounding of the components isreasonable, the cost is low, the juice is concentrated by the oral thick paste therapy method, the essences of the medicines are centralized, the amount is small, the quality is pure, and the digestion and absorbing are easy; the eating is convenient, the daily decoction is not required, the taste is sweet and comfortable, the oral thick paste is suitable for long-term taking, and the treatment effect on the cerebral arteriosclerosis is better.

The invention discloses an application of a traditional Chinese medicine composition in the preparation of medicines for treating cerebral arteriosclerosis. The traditional Chinese medicine composition comprises ginseng, leech, centipede, scorpio, ground beeltle, cicada slough, radix paeoniae rubra, borneol and the like, has the effects of supplementing qi and activating blood circulation as well as eliminating blood-stasis and freeing channels. Clinical tests prove that the traditional Chinese medicine composition can effectively treat the cerebral arteriosclerosis without adverse reactions found.